PharmiWeb.com - Global Pharma News & Resources

Articles

G-Protein Coupled Receptors  Market (GPCRs) represent a large and diverse group of membrane proteins involved in transmitting a variety of signals from outside the cell into the cell’s interior. These receptors play a pivotal role in numerous physiological processes and are implicated in various disease states, making them a prominent target for therapeutic drug development.
G-Protein Coupled Receptors (GPCR) Market Report Introduction G-Protein Coupled Receptors  Market (GPCRs) represent a large and diverse group of membrane proteins involved in transmitting a variety of signals from outside the cell into the cell’s interior. These receptors play a pivotal role in numerous physiological processes and are implicated in various disease states, making them a prominent target for the…
The Interventional Oncology Market is witnessing a dynamic shift as advanced, image-guided, minimally invasive therapies increasingly become a preferred treatment option for cancer patients. Valued at USD 3.9 billion in 2025, the global market is expanding at a compound annual growth rate (CAGR) of 7.2% over the forecast period.
The Interventional Oncology Market is witnessing a dynamic shift as advanced, image-guided, minimally invasive therapies increasingly become a preferred treatment option for cancer patients. Valued at USD 3.9 billion in 2025, the global market is expanding at a compound annual growth rate (CAGR) of 7.2% over the forecast period. This growth is fueled by technological innovations, rising cancer incidence, and a global focus on less invasive treatment modalities that…
Flexible spinal implants represent a significant advancement in spinal surgery and orthopedic healthcare. Designed to offer improved flexibility, reduced stress shielding, and more physiological motion preservation compared to traditional rigid spinal devices
Flexible Spinal Implants Market Report Introduction Flexible spinal implants represent a significant advancement in spinal surgery and orthopedic healthcare. Designed to offer improved flexibility, reduced stress shielding, and more physiological motion preservation compared to traditional rigid spinal devices, these implants are used in the treatment of various spinal disorders including degenerative disc disease, scoliosis, and spinal stenosis. The market is evolving with innovations aimed at improving patient outcomes, minimizing in…
Adopting a platform approach to designing new therapies could speed the delivery of innovative genomic treatments to patients. Danaher is working alongside biopharmaceutical developers, manufacturers and regulators to evolve the current drug development paradigm into a more efficient and sustainable process. Here, Vanessa Almendro, Vice President of Science and Technology, Head of Innovation, at Danaher Corporation, explains this paradigm shift and how industry leaders and regulators will need to work together to realize its potential.
Explain what you mean when you say biopharmaceutical innovation must shift from discovery to design?  Advances in genomics, proteomics and other molecular sciences are enabling researchers to move beyond the traditional method of discovery, which is a la…
Summary: Artificial intelligence (AI) and other innovations in data science are fueling major advances in healthcare, from biopharmaceutical development to patient diagnostics, but the use of these tools is still somewhat limited. Here, Jose-Carlos (“JC”) Gutierrez-Ramos, Senior Vice President and Chief Science Officer of Danaher, explains his vision for expanding access to these technologies, which he refers to as the “hyperscaling” of healthcare.
How do you define “hyperscaling” of healthcare?  Today, some biopharmaceutical developers are using AI-enabled technology to instantly interpret the data they generate and in the context of similar studies published by other researchers. Clinicians can order diagnostic tests for patients that will offer prognoses and treatment recommendation…
Data sovereignty is becoming a strategic priority for UK organisations, influencing data centre decisions beyond just performance or cost. As regulations tighten and technologies like AI demand faster, local processing, businesses are turning to UK-based infrastructure for security, compliance, and competitive edge. From private cloud to high-performance data centres, keeping data close is now key to both innovation and risk management.
Data sovereignty has become a critical consideration for those selecting data centre solutions. The concept that data is governed by the legal frameworks of the country where it is stored or collected underpins two key legislative instruments: the Data Protection Act 2018 (DPA 2018) and the UK General Data Protection Regulation (UK GDPR).   While both l…
Martin Kesselgruber, VP Global Project Management at Bachem, offers insights on the key measures for companies to consider for successful project outcomes
Robust project management is essential in any manufacturing business, particularly where strict regulations and complex production processes require maximum alignment between all involved functions.   As a Contract Development and Manufacturing Organisation (CDMO), Bachem has developed unique expertise in project management approaches and systems. CDMOs play a crucial role in supplying Active Pharmaceutical Ingredients (APIs) to biotech and pharmaceutical companies, involving all required steps like raw materials management, process development and validation, production, purification, and delivery.   To ensure efficiency and…
As the NHS continues to tackle the chronic workforce shortage, the importance of education and training cannot be underestimated. It is essential for clinicians to keep up with medical advancements, enhancing professional skills, and ultimately improving patient outcomes. In an ever-evolving field driven by technological advancements, continuing education is not just an option but a necessity for success and excellence. In this viewpoint, Mark Hitchman, Managing Director at Canon Medical Systems UK explains the importance in addressing education and training concerns, ensuring clinicians have the necessary support to manage today’s complex and often stressful working environment.
Trained workforce key to future-proofing the NHS By Mark Hitchman, Managing Director at Canon Medical Syst…
Nitrogen compounds are a crucial aspect of pharmaceutical chemistry, particularly in the development of antibiotics. Their unique chemical properties, including the ability to form multiple hydrogen bonds and engage in various interactions, make them indispensable in the fight against bacterial infections.
This article delves into the application of nitrogen compounds in antibiotic research and development, illustrating how they influence antibiotic efficacy.   Fundamental Properties of Nitrogen Compounds   Nitrogen compounds are defined as chemical substances containing nitrogen atoms within their molecular structure. In drug chemistry, these compounds are renowned for their diverse properties that directly impact their biological interactions. The presence of nitrogen affec…
This article explores the types, functions, and significance of polymer additives in various applications.
Polymer additives play a critical role in the processing and performance of polymer materials. These additives are substances included in the polymer matrix during manufacturing to modify the material's physical properties, improve processing qualities, or enhance performance characteristics.    Types of Polymer Additives Polymer additives can be classified into several categories based on their functions:   Plasticizers: These additives increase the flexibility, workability, and plasticity of polymers. Commonly used in polyvinyl chloride (PVC) formulations, plasticizers allow for easier processing while reducing brittleness.   Stabilizers: Stabilizers protect po…
Artificial Intelligence (AI) is no longer a futuristic concept in the pharmaceutical industry — it is today’s reality, revolutionizing how drugs are discovered, designed, and developed. The integration of AI into drug discovery is dramatically reshaping the landscape of biomedical research, offering the promise of accelerated timelines, reduced costs, improved success rates, and personalized medicine. The Artificial Intelligence in Drug Discovery Market is poised for massive growth, driven by technological advancements, increasing healthcare needs, and a booming pharmaceutical sector.
Introduction: The Convergence of AI and Life Sciences Traditionally, drug discovery is a time-consuming and costly process, often taking 10–15 years and billions of dollars to bring a single drug to market. Wi…
Selecting the appropriate alumina catalyst carrier is crucial in enhancing the overall efficiency and performance of chemical reactions across various industrial applications.
Selecting the appropriate alumina catalyst carrier is crucial in enhancing the overall efficiency and performance of chemical reactions across various industrial applications. This article provides guidance on the importance of these carriers, their characteristics, product offerings from Alfa Chemistry, and key considerations that inform their selection. What Are Alumina Carriers? Alumina carriers refer to the white powders or shaped solids that serve as supports for catalysts, significantly used across chemical industries. Approximately 70% of industrial supported catalysts utilize alumina carriers due to their abil…
Joe Makowiecki, Director, Product Management & Engineering, Product Solutions at Cytiva
Collaborations are important in biopharma manufacturing because biologic medicines, particularly new modalities, such as nucleic acid vaccines and cell and gene therapies, are complex medicines with equally complex manufacturing processes. Few, if any, companies possess all the capabilities, technologies, or infrastructure required to develop and produce these medicines independently. During the pandemic we saw how collaborations between governments, industry, and academic institutions accelerated the development and manufacture of the COVID-19 vaccines. Additionally, collaborations can alleviate some of the challenges by helping to reduce costs, provide access to expertise, speed up production, and redu…
In the fast-paced pharmaceutical industry, sales teams face increasing pressure to meet sales targets, engage healthcare professionals effectively, and stay ahead of constant product innovations. Yet, traditional sales training methods are often inadequate, failing to equip sales representatives with the skills they need to succeed.
Marina Hickson, Chief Executive Officer, Vivanti In the fast-paced pharmaceutical industry, sales teams face increasing pressure to meet sales targets, engage healthcare professionals effectively, and stay ahead of constant product innovations. Yet, traditional sales training methods are often inadequate, failing to equip sales representatives with the skills they need to succeed. A recent Salesforce ‘State of Sales’ Report (2024)[i] reveals that 84% of sales re…
Nutraceuticals refers to products that generally fall into the Dietary supplements / Food supplements. Typically the include concentrated bioactive compounds such as vitamins, minerals, herbal extracts or probiotics and are designed to deliver health benefits beyond basic nutrition. Top Nutraceutical Manufacturers in the UK
Nutraceuticals refers to products that generally fall into the Dietary supplements / Food supplements. Typically the include concentrated bioactive compounds such as vitamins, minerals, herbal extracts or probiotics and are designed to deliver health benefits beyond basic nutrition. Here's a list of some of the top Nutraceutical companies in the UK: https://www.pharmiweb.jobs/article/top-nutraceutical-manufacturers-in-the-uk
Violating ethical standards in clinical trials can lead to serious consequences, including harm to participants, invalidated data, legal action, and reputational damage. Ethical principles like informed consent, risk minimization, and confidentiality are crucial to ensure participant protection and study integrity. Notable cases, such as the Tuskegee Study and Pfizer’s Nigeria trial, highlight the dangers of unethical research. Detection often occurs through audits or whistleblowers. Prevention requires strict oversight, transparent communication, and continuous ethics training to uphold trust and safeguard human dignity in clinical research.
In clinical trials, ethical standards are more than just rules; they are the foundation of scientific integrity, safety, and trust. Violating these st…
Patient autonomy is a fundamental ethical principle in clinical research, emphasising the right of individuals to make informed, voluntary decisions about their participation. It is primarily expressed through the informed consent process, which ensures participants understand the study, its risks, and their rights—including the freedom to withdraw at any time. Respecting autonomy protects vulnerable populations from exploitation, promotes transparency, and fosters trust between researchers and participants. Cultural sensitivity, clear communication, and ongoing engagement are key to effectively upholding autonomy. Despite challenges like complex study designs, language barriers, and power imbalances, researchers must proactively work to support and respect patient autonomy throughout the research process, ensuring ethical integrity and participant dignity.
In the fast-paced pharmaceutical industry, sales teams face increasing pressure to meet sales targets, engage healthcare professionals effectively, and stay ahead of constant product innovations. Yet, traditional sales training methods are often inadequate, failing to equip sales representatives with the skills they need to succeed.
In the fast-paced pharmaceutical industry, sales teams face increasing pressure to meet sales targets, engage healthcare professionals effectively, and stay ahead of constant product innovations. Yet, traditional sales training methods are often inadequate, failing to equip sales representatives with the skills they need to succeed. A recent Salesforce ‘State of Sales’ Report (2024)[i] reveals that 84% of sales representatives failed to meet their targets…
The pharmaceutical sector has been making headlines for large-scale layoffs, department closures, and clinical trial failures. Though the issue is complex, a few trends have emerged showing causes for this disruption: cost-cutting to counteract low profit margins, competitive pressure from imminent patent cliffs, promising drug candidates failing clinical trials, and more.
The pharmaceutical sector has been making headlines for large-scale layoffs, department closures and clinical trial failures. Some companies have even declared bankruptcy in recent months. What is to blame for this disruption? If industry professionals understand what they are up against, they can prepare accordingly. Big Pharma Firms Are Letting People Go Big pharma firms are letting employees go, which could be the sta…
Search Highlights Recent top global hires for Venture Capital and Private Equity portfolio companies, covering a broad range of disciplines and sectors across Life Sciences, Health and Tech.
This quarter’s successful placements include: Function, Focus area, Location CEO, Exosome technologies, Italy CEO, CRO, France CEO, Cell & gene therapy tools, UK Chief Development Officer, Cell reprogramming, Sweden Chief Financial Officer, Antibody-drug conjugates, Germany/ US Chief Business Officer, Small molecule therapeutics, Switzerland/ US Chief Scientific Officer, AI platform technologies, UK Chief Commercial Officer, CDMO, UK Chief Technology & Operations Officer, Precision fermentation, Sweden Chief R&D Officer, Mitochondrial medicine, UK VP, Head of Biometrics, Oncology drug deve…